209 related articles for article (PubMed ID: 30940883)
1. Identification of Allosteric Inhibitors against Active Caspase-6.
Tubeleviciute-Aydin A; Beautrait A; Lynham J; Sharma G; Gorelik A; Deny LJ; Soya N; Lukacs GL; Nagar B; Marinier A; LeBlanc AC
Sci Rep; 2019 Apr; 9(1):5504. PubMed ID: 30940883
[TBL] [Abstract][Full Text] [Related]
2. Rare human Caspase-6-R65W and Caspase-6-G66R variants identify a novel regulatory region of Caspase-6 activity.
Tubeleviciute-Aydin A; Zhou L; Sharma G; Soni IV; Savinov SN; Hardy JA; LeBlanc AC
Sci Rep; 2018 Mar; 8(1):4428. PubMed ID: 29535332
[TBL] [Abstract][Full Text] [Related]
3. 'Polymorphism-aided' Selective Targeting and Inhibition of Caspase-6 by a Novel Allosteric Inhibitor Towards Efficient Alzheimer's Disease Treatment.
Kumi RO; Agoni C; Issahaku AR; Olotu FA; Soliman MES
Cell Biochem Biophys; 2020 Sep; 78(3):291-299. PubMed ID: 32592127
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6.
Heise CE; Murray J; Augustyn KE; Bravo B; Chugha P; Cohen F; Giannetti AM; Gibbons P; Hannoush RN; Hearn BR; Jaishankar P; Ly CQ; Shah K; Stanger K; Steffek M; Tang Y; Zhao X; Lewcock JW; Renslo AR; Flygare J; Arkin MR
PLoS One; 2012; 7(12):e50864. PubMed ID: 23227217
[TBL] [Abstract][Full Text] [Related]
5. Tailoring small molecules for an allosteric site on procaspase-6.
Murray J; Giannetti AM; Steffek M; Gibbons P; Hearn BR; Cohen F; Tam C; Pozniak C; Bravo B; Lewcock J; Jaishankar P; Ly CQ; Zhao X; Tang Y; Chugha P; Arkin MR; Flygare J; Renslo AR
ChemMedChem; 2014 Jan; 9(1):73-7, 2. PubMed ID: 24259468
[TBL] [Abstract][Full Text] [Related]
6. Identification of FDA-approved drugs as novel allosteric inhibitors of human executioner caspases.
Krishna Deepak RNV; Abdullah A; Talwar P; Fan H; Ravanan P
Proteins; 2018 Nov; 86(11):1202-1210. PubMed ID: 30194780
[TBL] [Abstract][Full Text] [Related]
7. A multipronged approach for compiling a global map of allosteric regulation in the apoptotic caspases.
Dagbay K; Eron SJ; Serrano BP; Velázquez-Delgado EM; Zhao Y; Lin D; Vaidya S; Hardy JA
Methods Enzymol; 2014; 544():215-49. PubMed ID: 24974292
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Associated Mutations in Caspase-6 Negatively Impact Catalytic Efficiency.
Dagbay KB; Hill ME; Barrett E; Hardy JA
Biochemistry; 2017 Aug; 56(34):4568-4577. PubMed ID: 28726391
[TBL] [Abstract][Full Text] [Related]
9. Dissecting an allosteric switch in caspase-7 using chemical and mutational probes.
Hardy JA; Wells JA
J Biol Chem; 2009 Sep; 284(38):26063-9. PubMed ID: 19581639
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting caspase-6 activation and catalytic activity for neurodegenerative diseases.
Flygare JA; Arkin MR
Curr Top Med Chem; 2014; 14(3):319-25. PubMed ID: 24283214
[TBL] [Abstract][Full Text] [Related]
11. Small Molecule Active Site Directed Tools for Studying Human Caspases.
Poreba M; Szalek A; Kasperkiewicz P; Rut W; Salvesen GS; Drag M
Chem Rev; 2015 Nov; 115(22):12546-629. PubMed ID: 26551511
[TBL] [Abstract][Full Text] [Related]
12. Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization.
Stanger K; Steffek M; Zhou L; Pozniak CD; Quan C; Franke Y; Tom J; Tam C; Krylova I; Elliott JM; Lewcock JW; Zhang Y; Murray J; Hannoush RN
Nat Chem Biol; 2012 Jul; 8(7):655-60. PubMed ID: 22683611
[TBL] [Abstract][Full Text] [Related]
13. Tri-arginine exosite patch of caspase-6 recruits substrates for hydrolysis.
MacPherson DJ; Mills CL; Ondrechen MJ; Hardy JA
J Biol Chem; 2019 Jan; 294(1):71-88. PubMed ID: 30420425
[TBL] [Abstract][Full Text] [Related]
14. A class of allosteric caspase inhibitors identified by high-throughput screening.
Feldman T; Kabaleeswaran V; Jang SB; Antczak C; Djaballah H; Wu H; Jiang X
Mol Cell; 2012 Aug; 47(4):585-95. PubMed ID: 22795132
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of caspase-3 by a competitive DARPin: molecular mimicry between native and designed inhibitors.
Schroeder T; Barandun J; Flütsch A; Briand C; Mittl PR; Grütter MG
Structure; 2013 Feb; 21(2):277-89. PubMed ID: 23333429
[TBL] [Abstract][Full Text] [Related]
16. Lazaroids U83836E and U74389G are potent, time-dependent inhibitors of caspase-1.
Kawarski M; Hagerman TK; Karver CE
Chem Biol Drug Des; 2015 Nov; 86(5):1049-54. PubMed ID: 25871734
[TBL] [Abstract][Full Text] [Related]
17. Caspase vinyl sulfone small molecule inhibitors prevent axonal degeneration in human neurons and reverse cognitive impairment in Caspase-6-overexpressing mice.
Pakavathkumar P; Noël A; Lecrux C; Tubeleviciute-Aydin A; Hamel E; Ahlfors JE; LeBlanc AC
Mol Neurodegener; 2017 Feb; 12(1):22. PubMed ID: 28241839
[TBL] [Abstract][Full Text] [Related]
18. Zinc-mediated allosteric inhibition of caspase-6.
Velázquez-Delgado EM; Hardy JA
J Biol Chem; 2012 Oct; 287(43):36000-11. PubMed ID: 22891250
[TBL] [Abstract][Full Text] [Related]
19. Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.
Kent CR; Bryja M; Gustafson HA; Kawarski MY; Lenti G; Pierce EN; Knopp RC; Ceja V; Pati B; Walters DE; Karver CE
Bioorg Med Chem Lett; 2016 Nov; 26(22):5476-5480. PubMed ID: 27777011
[TBL] [Abstract][Full Text] [Related]
20. Cytoprotective effect of selective small-molecule caspase inhibitors against staurosporine-induced apoptosis.
Wu J; Wang Y; Liang S; Ma H
Drug Des Devel Ther; 2014; 8():583-600. PubMed ID: 24920883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
